Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ochs

Showing results (401-410 of 541) with videos related to

Pageof 55
Sort By:
The American Journal of Medicine|March 30, 1984
Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseasesH D Ochs, S H Fischer, R J Wedgwood, et al.
Molecular Genetics & Genomic Medicine|February 19, 2020
The co-occurrence of Wilson disease and X-linked agammaglobulinemia in one family highlights the promising diagnostic potential of proteolytic analysisSheri A Poskanzer, Jenny Thies, Christopher J Collins, et al.
The New England Journal of Medicine|March 3, 1977
Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complexH D Ochs, S I Rosenfeld, E D Thomas, et al.
Nature Medicine|May 2, 2002
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacementAlessandro Aiuti, Sergio Vai, Alessandra Mortellaro, et al.
Frontiers in Immunology|November 17, 2018
Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) SyndromeEleonora Gambineri, Sara Ciullini Mannurita, David Hagin, et al.
The Journal of Experimental Medicine|August 10, 2000
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cellsS Parolini, C Bottino, M Falco, et al.
Nature Immunology|September 6, 2003
Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombinationKohsuke Imai, Geir Slupphaug, Wen-I Lee, et al.
Transplantation|February 1, 1982
Immunological recovery in 48 patients following syngeneic marrow transplantation or hematological malignancyR P Witherspoon, K Kopecky, R F Storb, et al.
Journal of Virology|June 1, 1988
Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2R E Benveniste, W R Morton, E A Clark, et al.
Blood|July 31, 2004
Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlationYinzhu Jin, Cinzia Mazza, Jacinda R Christie, et al.
Pageof 55

Showing results (401-410 of 541) with videos related to

Sort By:
Pageof 55
The American Journal of Medicine|March 30, 1984
Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseasesH D Ochs, S H Fischer, R J Wedgwood, et al.
Molecular Genetics & Genomic Medicine|February 19, 2020
The co-occurrence of Wilson disease and X-linked agammaglobulinemia in one family highlights the promising diagnostic potential of proteolytic analysisSheri A Poskanzer, Jenny Thies, Christopher J Collins, et al.
The New England Journal of Medicine|March 3, 1977
Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complexH D Ochs, S I Rosenfeld, E D Thomas, et al.
Nature Medicine|May 2, 2002
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacementAlessandro Aiuti, Sergio Vai, Alessandra Mortellaro, et al.
Frontiers in Immunology|November 17, 2018
Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) SyndromeEleonora Gambineri, Sara Ciullini Mannurita, David Hagin, et al.
The Journal of Experimental Medicine|August 10, 2000
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cellsS Parolini, C Bottino, M Falco, et al.
Nature Immunology|September 6, 2003
Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombinationKohsuke Imai, Geir Slupphaug, Wen-I Lee, et al.
Transplantation|February 1, 1982
Immunological recovery in 48 patients following syngeneic marrow transplantation or hematological malignancyR P Witherspoon, K Kopecky, R F Storb, et al.
Journal of Virology|June 1, 1988
Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2R E Benveniste, W R Morton, E A Clark, et al.
Blood|July 31, 2004
Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlationYinzhu Jin, Cinzia Mazza, Jacinda R Christie, et al.
Pageof 55